287 related articles for article (PubMed ID: 23819566)
1. Promoter methylation and expression of TIMP3 gene in gastric cancer.
Guan Z; Zhang J; Song S; Dai D
Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
[TBL] [Abstract][Full Text] [Related]
2. Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma.
Guo W; Dong Z; Chen Z; Yang Z; Wen D; Kuang G; Guo Y; Shan B
Cancer Invest; 2009 May; 27(4):459-65. PubMed ID: 19160099
[TBL] [Abstract][Full Text] [Related]
3. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
5. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
[TBL] [Abstract][Full Text] [Related]
6. Aberrant CpG island methylation in early-onset sporadic gastric carcinoma.
Kim HC; Kim JC; Roh SA; Yu CS; Yook JH; Oh ST; Kim BS; Park KC; Chang R
J Cancer Res Clin Oncol; 2005 Nov; 131(11):733-40. PubMed ID: 16075282
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
9. Detection of promoter hypermethylation of the CpG island of E-cadherin in gastric cardiac adenocarcinoma.
Guo W; Dong Z; Guo Y; Kuang G; Yang Z; Chen Z
Eur J Med Res; 2009 Sep; 14(10):453-8. PubMed ID: 19748854
[TBL] [Abstract][Full Text] [Related]
10. Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer.
Zhang H; Song Y; Xia P; Cheng Y; Guo Q; Diao D; Wang W; Wu X; Liu D; Dang C
Med Oncol; 2014 Feb; 31(2):830. PubMed ID: 24381142
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections.
Ghadami E; Nikbakhsh N; Fattahi S; Kosari-Monfared M; Ranaee M; Taheri H; Amjadi-Moheb F; Godazandeh G; Shafaei S; Nosrati A; Pilehchian Langroudi M; Samadani AA; Amirbozorgi G; Mirnia V; Akhavan-Niaki H
J Cell Physiol; 2019 Apr; 234(4):4115-4124. PubMed ID: 30132887
[TBL] [Abstract][Full Text] [Related]
12. GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer.
Eftang LL; Klajic J; Kristensen VN; Tost J; Esbensen QY; Blom GP; Bukholm IR; Bukholm G
BMC Cancer; 2016 Mar; 16():225. PubMed ID: 26984265
[TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.
Shinojima T; Yu Q; Huang SK; Li M; Mizuno R; Liu ET; Hoon DS; Lessard L
Epigenetics; 2012 Nov; 7(11):1279-89. PubMed ID: 23023649
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression and aberrant methylation of RASSF5A correlates with malignant progression of gastric cardia adenocarcinoma.
Han L; Dong Z; Wang C; Guo Y; Shen S; Kuang G; Guo W
Mol Carcinog; 2015 Dec; 54(12):1722-33. PubMed ID: 25420558
[TBL] [Abstract][Full Text] [Related]
16. [Promoter methylation and expression of Runx3 gene in gastric cancer].
Li LY; Li JK; Shen Y; Yu L; Zhang JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364
[TBL] [Abstract][Full Text] [Related]
17. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
20. Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.
Das AM; Koljenović S; Oude Ophuis CM; van der Klok T; Galjart B; Nigg AL; van Cappellen WA; Noordhoek Hegt V; Dinjens WN; Atmodimedjo PN; Vermeulen CE; Verhoef C; Eggermont AM; ten Hagen TL
Eur J Cancer; 2016 Jan; 53():135-43. PubMed ID: 26707830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]